BRIEF DESCRIPTION
Microbial Medical is launching novel imaging agents and drugs for diagnosing and treating bacterial and fungal infections, based on a platform technology for chemically linking existing medical compounds with sugars that pathogens consume and human cells reject. The launch products are contrast agents that enable common medical scanners to image infection. The next products are antibiotics that address antibiotic resistance and have reduced toxicity.